Aclaris reports 3Q loss

MALVERN, Pa. (AP) _ Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $18.2 million in its third quarter.

The Malvern, Pennsylvania-based company said it had a loss of 63 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.

The specialty pharmaceutical company posted revenue of $684,000 in the period.

Aclaris shares have fallen 12 percent since the beginning of the year. The stock has climbed 15 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS